user

Tumor Dosimetry And Radiobiological Study For High-Activity 131I-mIBG Therapy In The Management Of Refractory/Relapsed Neuroblastoma

被引：0
|
作者：
Polito, C. [1 ]
Cassano, B. [1 ]
Genovese, E. [1 ]
Longo, M. [2 ]
Donatiello, S. [1 ]
Insero, T. [1 ]
Valeri, S. [1 ]
Villani, M. F. [1 ]
Castellano, A. [1 ]
Garganese, M. C. [1 ]
Cannata, V. [1 ]
机构：
[1] IRCCS Bambino Gesu Childrens Hosp, Rome, Italy
[2] Arcispedale St Anna Hosp, Ferrara, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0221
引用
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [41] Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I-MIBG in patients with relapsed/refractory neuroblastoma
    Batra, Vandana
    Gikandi, Ajami
    Pawel, Bruce
    Martinez, Daniel
    Granger, M. Meaghan
    Marachelian, Araz
    Park, Julie R.
    Maris, John M.
    Vo, Kieuhoa T.
    Matthay, Katherine K.
    DuBois, Steven G.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (01)
  • [42] Radiation dosimetry for I-131-mIBG therapy of neuroblastoma
    Flower, MA
    Fielding, SL
    PHYSICS IN MEDICINE AND BIOLOGY, 1996, 41 (10): : 1933 - 1940
  • [43] Dosimetry in 131I-MIBG therapy: moving toward personalized medicine
    Chiesa, C.
    Castellani, R.
    Mira, M.
    Lorenzoni, A.
    Flux, G. D.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (02): : 161 - 170
  • [44] Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu' Children's Hospital experience
    Altini, Claudio
    Villani, Maria F.
    Di Giannatale, Angela
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Serra, Annalisa
    Castellano, Aurora
    Cannata, Vittorio
    Garganese, Maria C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (02) : 129 - 144
  • [45] Targeted Therapy with Low Doses of 131I-MIBG is Effective for Disease Palliation in Highly Refractory Neuroblastoma
    Ben-Arush, Myriam Weyl
    Ben Barak, Ayelet
    Bar-Deroma, Raquel
    Ash, Shifra
    Goldstein, Gal
    Golan, Hanna
    Houri, Haim
    Waldman, Dalia
    Nevo, Neta
    Bar Shalom, Rachel
    Berniger, Alison
    Nevelsky, Alexander
    Toren, Amos
    Yaniv, Isaac
    Kuten, Abraham
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (01): : 31 - 34
  • [46] A correlation study between clinical outcome and absorbed dose to organs at risk and lesions for patients with High-Risk Neuroblastoma administered with high-activity therapy of 131I-mIBG
    Cassano, B.
    Pizzoferro, M.
    Valeri, S.
    Donatiello, S.
    Polito, C.
    Ciucci, D.
    Martire, F.
    Castellano, A.
    Altini, C.
    Garganese, M. C.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S315 - S316
  • [47] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
    Lessig, Megan Kinnear
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
  • [48] Treatment planning for 131I-mIBG Radionuclide therapy of high-risk neuroblastoma based on patient-specific Dosimetry
    Buckley, S.
    Saran, F.
    Gaze, M.
    Hindorf, C.
    Chittenden, S.
    Lancaster, D.
    Pearson, A.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S179 - S179
  • [49] Dosimetry during therapy in neuroblastoma paediatric patients treated with 131I-mIBG -: Methodology optimization and preliminary results
    Chiesa, C
    Albertini, F
    Castellani, MR
    Pavesi, R
    Luksch, R
    Bombardieri, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S474 - S474
  • [50] Toxicity of 131I-MIBG combined with high-dose chemotherapy in children with refractory neuroblastoma.
    Amoroso, L.
    Villavecchia, G.
    Cabria, M.
    Piccardo, A.
    Conte, M.
    Nantron, M.
    Garaventa, A.
    De Bernardi, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345